Hematology is a branch of medicine concerned with the study of blood, blood disease and the organs involved in forming blood.
This report aims to provide a comprehensive presentation of the global market for Hematology Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Therapies. This report contains market size and forecasts of Hematology Therapies in global, including the following market information:
Global Hematology Therapies Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hematology Therapies market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hematology Instruments Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hematology Therapies include Abbott Laboratories, Bio-Rad Laboratories, Roche, HORIBA, Beckman Coulter, Bayer, Sysmex, Ortho Clinical Diagnostic and Siemens Healthineers, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hematology Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hematology Therapies Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hematology Therapies Market Segment Percentages, by Type, 2022 (%)
Hematology Instruments
Hematology Consumables
Global Hematology Therapies Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hematology Therapies Market Segment Percentages, by Application, 2022 (%)
Diagnostic Laboratories
Hospitals and Clinics
Academic Institutes
Others
Global Hematology Therapies Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hematology Therapies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hematology Therapies revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hematology Therapies revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Bio-Rad Laboratories
Roche
HORIBA
Beckman Coulter
Bayer
Sysmex
Ortho Clinical Diagnostic
Siemens Healthineers
HemoCue
Boule Diagnostics
EKF Diagnostics
Drew Scientific
Mindray Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hematology Therapies, market overview.
Chapter 2: Global Hematology Therapies market size in revenue.
Chapter 3: Detailed analysis of Hematology Therapies company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hematology Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hematology Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hematology Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hematology Therapies Overall Market Size
2.1 Global Hematology Therapies Market Size: 2022 VS 2029
2.2 Global Hematology Therapies Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hematology Therapies Players in Global Market
3.2 Top Global Hematology Therapies Companies Ranked by Revenue
3.3 Global Hematology Therapies Revenue by Companies
3.4 Top 3 and Top 5 Hematology Therapies Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hematology Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hematology Therapies Players in Global Market
3.6.1 List of Global Tier 1 Hematology Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Hematology Therapies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hematology Therapies Market Size Markets, 2022 & 2029
4.1.2 Hematology Instruments
4.1.3 Hematology Consumables
4.2 By Type - Global Hematology Therapies Revenue & Forecasts
4.2.1 By Type - Global Hematology Therapies Revenue, 2018-2023
4.2.2 By Type - Global Hematology Therapies Revenue, 2024-2029
4.2.3 By Type - Global Hematology Therapies Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hematology Therapies Market Size, 2022 & 2029
5.1.2 Diagnostic Laboratories
5.1.3 Hospitals and Clinics
5.1.4 Academic Institutes
5.1.5 Others
5.2 By Application - Global Hematology Therapies Revenue & Forecasts
5.2.1 By Application - Global Hematology Therapies Revenue, 2018-2023
5.2.2 By Application - Global Hematology Therapies Revenue, 2024-2029
5.2.3 By Application - Global Hematology Therapies Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Hematology Therapies Market Size, 2022 & 2029
6.2 By Region - Global Hematology Therapies Revenue & Forecasts
6.2.1 By Region - Global Hematology Therapies Revenue, 2018-2023
6.2.2 By Region - Global Hematology Therapies Revenue, 2024-2029
6.2.3 By Region - Global Hematology Therapies Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Hematology Therapies Revenue, 2018-2029
6.3.2 US Hematology Therapies Market Size, 2018-2029
6.3.3 Canada Hematology Therapies Market Size, 2018-2029
6.3.4 Mexico Hematology Therapies Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Hematology Therapies Revenue, 2018-2029
6.4.2 Germany Hematology Therapies Market Size, 2018-2029
6.4.3 France Hematology Therapies Market Size, 2018-2029
6.4.4 U.K. Hematology Therapies Market Size, 2018-2029
6.4.5 Italy Hematology Therapies Market Size, 2018-2029
6.4.6 Russia Hematology Therapies Market Size, 2018-2029
6.4.7 Nordic Countries Hematology Therapies Market Size, 2018-2029
6.4.8 Benelux Hematology Therapies Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Hematology Therapies Revenue, 2018-2029
6.5.2 China Hematology Therapies Market Size, 2018-2029
6.5.3 Japan Hematology Therapies Market Size, 2018-2029
6.5.4 South Korea Hematology Therapies Market Size, 2018-2029
6.5.5 Southeast Asia Hematology Therapies Market Size, 2018-2029
6.5.6 India Hematology Therapies Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Hematology Therapies Revenue, 2018-2029
6.6.2 Brazil Hematology Therapies Market Size, 2018-2029
6.6.3 Argentina Hematology Therapies Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hematology Therapies Revenue, 2018-2029
6.7.2 Turkey Hematology Therapies Market Size, 2018-2029
6.7.3 Israel Hematology Therapies Market Size, 2018-2029
6.7.4 Saudi Arabia Hematology Therapies Market Size, 2018-2029
6.7.5 UAE Hematology Therapies Market Size, 2018-2029
7 Hematology Therapies Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Hematology Therapies Major Product Offerings
7.1.4 Abbott Laboratories Hematology Therapies Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Bio-Rad Laboratories
7.2.1 Bio-Rad Laboratories Company Summary
7.2.2 Bio-Rad Laboratories Business Overview
7.2.3 Bio-Rad Laboratories Hematology Therapies Major Product Offerings
7.2.4 Bio-Rad Laboratories Hematology Therapies Revenue in Global Market (2018-2023)
7.2.5 Bio-Rad Laboratories Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Hematology Therapies Major Product Offerings
7.3.4 Roche Hematology Therapies Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 HORIBA
7.4.1 HORIBA Company Summary
7.4.2 HORIBA Business Overview
7.4.3 HORIBA Hematology Therapies Major Product Offerings
7.4.4 HORIBA Hematology Therapies Revenue in Global Market (2018-2023)
7.4.5 HORIBA Key News & Latest Developments
7.5 Beckman Coulter
7.5.1 Beckman Coulter Company Summary
7.5.2 Beckman Coulter Business Overview
7.5.3 Beckman Coulter Hematology Therapies Major Product Offerings
7.5.4 Beckman Coulter Hematology Therapies Revenue in Global Market (2018-2023)
7.5.5 Beckman Coulter Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Hematology Therapies Major Product Offerings
7.6.4 Bayer Hematology Therapies Revenue in Global Market (2018-2023)
7.6.5 Bayer Key News & Latest Developments
7.7 Sysmex
7.7.1 Sysmex Company Summary
7.7.2 Sysmex Business Overview
7.7.3 Sysmex Hematology Therapies Major Product Offerings
7.7.4 Sysmex Hematology Therapies Revenue in Global Market (2018-2023)
7.7.5 Sysmex Key News & Latest Developments
7.8 Ortho Clinical Diagnostic
7.8.1 Ortho Clinical Diagnostic Company Summary
7.8.2 Ortho Clinical Diagnostic Business Overview
7.8.3 Ortho Clinical Diagnostic Hematology Therapies Major Product Offerings
7.8.4 Ortho Clinical Diagnostic Hematology Therapies Revenue in Global Market (2018-2023)
7.8.5 Ortho Clinical Diagnostic Key News & Latest Developments
7.9 Siemens Healthineers
7.9.1 Siemens Healthineers Company Summary
7.9.2 Siemens Healthineers Business Overview
7.9.3 Siemens Healthineers Hematology Therapies Major Product Offerings
7.9.4 Siemens Healthineers Hematology Therapies Revenue in Global Market (2018-2023)
7.9.5 Siemens Healthineers Key News & Latest Developments
7.10 HemoCue
7.10.1 HemoCue Company Summary
7.10.2 HemoCue Business Overview
7.10.3 HemoCue Hematology Therapies Major Product Offerings
7.10.4 HemoCue Hematology Therapies Revenue in Global Market (2018-2023)
7.10.5 HemoCue Key News & Latest Developments
7.11 Boule Diagnostics
7.11.1 Boule Diagnostics Company Summary
7.11.2 Boule Diagnostics Business Overview
7.11.3 Boule Diagnostics Hematology Therapies Major Product Offerings
7.11.4 Boule Diagnostics Hematology Therapies Revenue in Global Market (2018-2023)
7.11.5 Boule Diagnostics Key News & Latest Developments
7.12 EKF Diagnostics
7.12.1 EKF Diagnostics Company Summary
7.12.2 EKF Diagnostics Business Overview
7.12.3 EKF Diagnostics Hematology Therapies Major Product Offerings
7.12.4 EKF Diagnostics Hematology Therapies Revenue in Global Market (2018-2023)
7.12.5 EKF Diagnostics Key News & Latest Developments
7.13 Drew Scientific
7.13.1 Drew Scientific Company Summary
7.13.2 Drew Scientific Business Overview
7.13.3 Drew Scientific Hematology Therapies Major Product Offerings
7.13.4 Drew Scientific Hematology Therapies Revenue in Global Market (2018-2023)
7.13.5 Drew Scientific Key News & Latest Developments
7.14 Mindray Medical
7.14.1 Mindray Medical Company Summary
7.14.2 Mindray Medical Business Overview
7.14.3 Mindray Medical Hematology Therapies Major Product Offerings
7.14.4 Mindray Medical Hematology Therapies Revenue in Global Market (2018-2023)
7.14.5 Mindray Medical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hematology Therapies Market Opportunities & Trends in Global Market
Table 2. Hematology Therapies Market Drivers in Global Market
Table 3. Hematology Therapies Market Restraints in Global Market
Table 4. Key Players of Hematology Therapies in Global Market
Table 5. Top Hematology Therapies Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hematology Therapies Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hematology Therapies Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hematology Therapies Product Type
Table 9. List of Global Tier 1 Hematology Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hematology Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hematology Therapies Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Hematology Therapies Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hematology Therapies Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Hematology Therapies Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Hematology Therapies Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hematology Therapies Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Hematology Therapies Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Hematology Therapies Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hematology Therapies Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Hematology Therapies Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hematology Therapies Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Hematology Therapies Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hematology Therapies Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Hematology Therapies Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hematology Therapies Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Hematology Therapies Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hematology Therapies Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Hematology Therapies Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hematology Therapies Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Hematology Therapies Product Offerings
Table 32. Abbott Laboratories Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Bio-Rad Laboratories Company Summary
Table 35. Bio-Rad Laboratories Hematology Therapies Product Offerings
Table 36. Bio-Rad Laboratories Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 37. Bio-Rad Laboratories Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Hematology Therapies Product Offerings
Table 40. Roche Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Key News & Latest Developments
Table 42. HORIBA Company Summary
Table 43. HORIBA Hematology Therapies Product Offerings
Table 44. HORIBA Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 45. HORIBA Key News & Latest Developments
Table 46. Beckman Coulter Company Summary
Table 47. Beckman Coulter Hematology Therapies Product Offerings
Table 48. Beckman Coulter Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 49. Beckman Coulter Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer Hematology Therapies Product Offerings
Table 52. Bayer Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 53. Bayer Key News & Latest Developments
Table 54. Sysmex Company Summary
Table 55. Sysmex Hematology Therapies Product Offerings
Table 56. Sysmex Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 57. Sysmex Key News & Latest Developments
Table 58. Ortho Clinical Diagnostic Company Summary
Table 59. Ortho Clinical Diagnostic Hematology Therapies Product Offerings
Table 60. Ortho Clinical Diagnostic Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 61. Ortho Clinical Diagnostic Key News & Latest Developments
Table 62. Siemens Healthineers Company Summary
Table 63. Siemens Healthineers Hematology Therapies Product Offerings
Table 64. Siemens Healthineers Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 65. Siemens Healthineers Key News & Latest Developments
Table 66. HemoCue Company Summary
Table 67. HemoCue Hematology Therapies Product Offerings
Table 68. HemoCue Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 69. HemoCue Key News & Latest Developments
Table 70. Boule Diagnostics Company Summary
Table 71. Boule Diagnostics Hematology Therapies Product Offerings
Table 72. Boule Diagnostics Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 73. Boule Diagnostics Key News & Latest Developments
Table 74. EKF Diagnostics Company Summary
Table 75. EKF Diagnostics Hematology Therapies Product Offerings
Table 76. EKF Diagnostics Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 77. EKF Diagnostics Key News & Latest Developments
Table 78. Drew Scientific Company Summary
Table 79. Drew Scientific Hematology Therapies Product Offerings
Table 80. Drew Scientific Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 81. Drew Scientific Key News & Latest Developments
Table 82. Mindray Medical Company Summary
Table 83. Mindray Medical Hematology Therapies Product Offerings
Table 84. Mindray Medical Hematology Therapies Revenue (US$, Mn) & (2018-2023)
Table 85. Mindray Medical Key News & Latest Developments
List of Figures
Figure 1. Hematology Therapies Segment by Type in 2022
Figure 2. Hematology Therapies Segment by Application in 2022
Figure 3. Global Hematology Therapies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hematology Therapies Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hematology Therapies Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hematology Therapies Revenue in 2022
Figure 8. By Type - Global Hematology Therapies Revenue Market Share, 2018-2029
Figure 9. By Application - Global Hematology Therapies Revenue Market Share, 2018-2029
Figure 10. By Type - Global Hematology Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Hematology Therapies Revenue Market Share, 2018-2029
Figure 12. By Application - Global Hematology Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Hematology Therapies Revenue Market Share, 2018-2029
Figure 14. By Region - Global Hematology Therapies Revenue Market Share, 2018-2029
Figure 15. By Country - North America Hematology Therapies Revenue Market Share, 2018-2029
Figure 16. US Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Hematology Therapies Revenue Market Share, 2018-2029
Figure 20. Germany Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 21. France Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Hematology Therapies Revenue Market Share, 2018-2029
Figure 28. China Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 32. India Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Hematology Therapies Revenue Market Share, 2018-2029
Figure 34. Brazil Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Hematology Therapies Revenue Market Share, 2018-2029
Figure 37. Turkey Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Hematology Therapies Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bio-Rad Laboratories Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. HORIBA Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Beckman Coulter Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bayer Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sysmex Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Ortho Clinical Diagnostic Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Siemens Healthineers Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. HemoCue Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Boule Diagnostics Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. EKF Diagnostics Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Drew Scientific Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Mindray Medical Hematology Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
